PARP9 knockdown confers protection against chemoresistance and immune escape of breast cancer cells by blocking the PI3K/AKT pathway
Introduction This study probes the mechanism of the PARP9/PI3K/AKT/PD-L1 axis in the chemoresistance and immune escape of breast cancer cells. Material and methods The expression of related genes was detected in MCF-7/FUL cells. After MCF-7/FUL cells were treated with sh-PARP9 and/or the PI3K/AKT p...
Huvudupphovsmän: | Tao Hong, Dingxiang Dong, Jun Li, Lin Wang |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Termedia Publishing House
2023-03-01
|
Serie: | Archives of Medical Science |
Ämnen: | |
Länkar: | https://www.archivesofmedicalscience.com/PARP9-knockdown-confers-protection-against-chemoresistance-and-immune-escape-of-breast,161444,0,2.html |
Liknande verk
Liknande verk
-
CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway
av: Ruijie Zhang, et al.
Publicerad: (2017-09-01) -
INPP4B inhibits glioma cell proliferation and immune escape via inhibition of the PI3K/AKT signaling pathway
av: Xiaoming Sun, et al.
Publicerad: (2022-09-01) -
Interstitial brachytherapy combined with PARP inhibitors in the treatment of chemoresistant recurrent epithelial ovarian cancer: A case report
av: Yuan Bian, et al.
Publicerad: (2022-12-01) -
Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma
av: Keisuke Okuno, et al.
Publicerad: (2022-09-01) -
Akt isoforms differentially provide for chemoresistance in prostate cancer
av: Bo Ma, et al.
Publicerad: (2022-05-01)